About Richard Larson
Form D filings for Metabolics Pharma in 2024 list Richard Larson as chief executive officer and director.
Form D filings also name Richard Larson as an executive officer at Enterin.
Richard Larson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Richard Larson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Richard Larson works with at each company, as listed on that company's latest Form D.
Metabolics Pharma, Inc. · Form D, Sep 19, 2024
MK
Mark Kamp
Director
JD
John Dessouki
Executive officer and director
MF
Mark Finn
Director
BM
Barry Miller
Director
JB
Jay Brammer
Director
Enterin, Inc. · Form D, Dec 6, 2023
MZ
Michael Zasloff
Director
DM
David McCullough
Chief Executive Officer and director
BM
Barry Miller
Director
DM
Don Munoz
Director
KW
Katherine Wolf
Executive officer
RM
Roger Mills
Director
WK
William Kinney
Executive officer
JB
Jay Brammer
Director
RP
Richard Propper
Director
MF
Mark Finn
Director